Stock Events

Stock Events

HLS Therapeutics (HLTRF) Q3 2024 Earnings

8AugConfirmed

Aug 22

Nov 22

Q2 2024

Q3 2024

-0.28

-0.21

-0.14

-0.07

Details

Expected EPS

-0.152233

Actual EPS

-0.18

Surprise EPS

-0.03

Surprise Percent

+18.24%

Description

HLS Therapeutics (HLTRF) has reported earnings of -0.18 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.